Filing Details
- Accession Number:
- 0001140361-24-018029
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-04 18:11:29
- Reporting Period:
- 2024-04-02
- Accepted Time:
- 2024-04-04 18:11:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1840904 | Atai Life Sciences N.v. | ATAI | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1976640 | Nagengast Anne Johnson | Wallstrasse 16 Berlin 2M 10179 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2024-04-02 | 27,410 | $1.85 | 73,590 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents shares sold to satisfy the Reporting Person's tax liability on vesting of restricted stock units.
Billionaire Hedge Funds
